Ars Pharmaceuticals Inc (SPRY)

Total Costs & Expenses

$333.19M

TTM · Period ending: · USD

SPRY logo

SPRY Total Costs & Expenses

Latest reported$333.19M
SPRY TTM Total Costs & Expenses ($31.74M → $333.19M)
High-resolution chart · PNG

SPRY total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ars Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
333,194,000
301,402,000
263,726,000
233,558,000
171,681,000
124,190,000
92,232,000
63,074,000
57,236,000
62,009,000
67,550,000
72,767,000
61,608,000
47,803,000
36,832,000
27,104,000
26,429,000
26,171,500
24,960,000
32,346,000
32,665,000
31,356,500
31,737,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.